✦ LIBER ✦

Identification of target genes within an amplicon at 14q12-q13 in esophageal squamous cell carcinoma

✍ Scribed by Kohichiroh Yasui; Issei Imoto; Yoji Fukuda; Atiphan Pimkhaokham; Zeng-Quen Yang; Takuya Naruto; Yutaka Shimada; Yusuke Nakamura; Johji Inazawa

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 194 KB
Volume: 32
Category: Article
ISSN: 1045-2257
DOI: 10.1002/gcc.1172

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Comparative genomic hybridization studies have revealed frequent amplification of the 14q12‐q13 region in esophageal squamous cell carcinoma (ESC) cell lines. To identify genes targeted for amplification, we first defined the minimal common region of amplification using fluorescence in situ hybridization in affected ESC cell lines. The amplicon covered about 6 Mb, between markers D14S1034 and L18528. Then we screened 32 ESC cell lines to discern amplifications and expression levels of 26 expressed sequence tags (ESTs) that had been localized to the amplified region. Five known genes (BAZ1A, SRP54, NFKBIA, MBIP, and HNF3A) and two uncharacterized ESTs (GenBank Accession numbers AA991861 and AA167732) within the amplicon showed amplification and consequent overexpression. Two of these transcripts were amplified in three of the primary ESCs we examined. Our findings suggest that these seven genes are candidate targets of the amplification mechanism and therefore may be associated, together or separately, with development and progression of ESC. © 2001 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

CDK4 is a probable target gene in a nove

CDK4 is a probable target gene in a novel amplicon at 12q13.3–q14.1 in lung cancer

✍ Harriet Wikman; Penny Nymark; Aki Väyrynen; Sonata Jarmalaite; Anne Kallioniemi; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB

## Abstract Several chromosomal regions are recurrently amplified or deleted in lung tumors, but little is known about the underlying genes, which could be important mediators in tumor formation or progression. In lung cancer, the RB1–CCND1–CDKN2A pathway, involved in the G1–S transition, is damage

MYEOV, a gene at 11q13, is coamplified w

MYEOV, a gene at 11q13, is coamplified withCCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas

✍ J. W. G. Janssen; I. Imoto; J. Inoue; Y. Shimada; M. Ueda; M. Imamura; C. R. Bar 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

Comparative genomic hybridization of squ

Comparative genomic hybridization of squamous cell carcinoma of the esophagus: The possible involvement of the DP1 gene in the 13q34 amplicon

✍ Takashi Shinomiya; Toshiki Mori; Yoji Ariyama; Tomoya Sakabe; Yoji Fukuda; Yasus 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

We investigated copy number aberrations in 29 primary tumors and 12 cell lines of esophageal squamous cell carcinoma (ESC) using comparative genomic hybridization. In the primary tumors, the most common sites of copy number gains were 3q26.3-27 (45%), 8q24 (41%), 5p15 (38%), Xq27-28 (38%), 14q32 (31